C12N 2320/32
Special delivery means
Official title: Special delivery means, e.g. tissue-specific
C12N2320/32 (Special delivery means) appears on 1,840 US grants and 3,731 published applications in this corpus.
Search patents in C12N- Granted patents
- 1,840
- Published applications
- 3,731
- Assignees
- 1,140
- Inventors
- 5,732
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 2 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 1 |
| 2002 | 1 | 3 |
| 2003 | 1 | 6 |
| 2004 | 0 | 17 |
| 2005 | 1 | 71 |
| 2006 | 4 | 41 |
| 2007 | 2 | 40 |
| 2008 | 2 | 51 |
| 2009 | 12 | 68 |
| 2010 | 17 | 92 |
| 2011 | 33 | 113 |
| 2012 | 41 | 115 |
| 2013 | 43 | 133 |
| 2014 | 70 | 122 |
| 2015 | 93 | 168 |
| 2016 | 115 | 248 |
| 2017 | 142 | 229 |
| 2018 | 167 | 216 |
| 2019 | 165 | 263 |
| 2020 | 149 | 215 |
| 2021 | 133 | 300 |
| 2022 | 145 | 264 |
| 2023 | 142 | 265 |
| 2024 | 128 | 302 |
| 2025 | 142 | 249 |
| 2026 | 87 | 139 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- RNAi constructs and methods for inhibiting LPA expression22 Sep 2026US 12,742,169 B2Amgen Inc.
- Sex-linked RNAi insecticide materials and methods25 Aug 2026US 12,714,111 B2Indiana University Research and Technology Corporation
- Delivery of nucleic acids, proteins and small molecules in vitreous vesicular bodies18 Aug 2026US 12,708,647 B2Cornell University
- Methods of making targeted vesicles, and compositions made thereby18 Aug 2026US 12,708,670 B2University of Georgia Research Foundation, Inc.
- Nanometric pharmaceutical composition in the form of liposomes or nanoemulsion containing specific sequences of interference RNA18 Aug 2026US 12,708,671 B2
- Modulating apolipoprotein (a) expression8 Oct 2026US 2026/0308584 A1Ionis Pharmaceuticals, Inc.
- Methods of minimising effects of smoke exposure8 Oct 2026US 2026/0308597 A1Rage Biotech Pty Ltd
- Biomimetic proteolipid nanovesicles for delivery of nucleic acids1 Oct 2026US 2026/0294808 A1The Methodist Hospital
- Compositions, systems and methods for programming immune cell function through targeted gene regulation1 Oct 2026US 2026/0297545 A1Duke University
- Methods and compositions for modifying genetic repeats1 Oct 2026US 2026/0297547 A1The General Hospital Corporation
Most cited
By later US patents
- Cationic lipids and methods for the delivery of therapeutic agents380US 8,569,256 B2Protiva Biotherapeutics, Inc. · 2013
- Lipid formulation340US 8,158,601 B2Alnylam Pharmaceuticals, Inc. · 2012
- Lipid formulations for nucleic acid delivery334US 8,058,069 B2Protiva Biotherapeutics, Inc. · 2011
- Lipid encapsulated interfering RNA265US 7,799,565 B2Protiva Biotherapeutics, Inc. · 2010
- Site specific delivery of nucleic acids by combining targeting ligands with endosomolytic components256US 9,345,780 B2Tekmira Pharmaceuticals Corporation · 2016